✦ LIBER ✦

Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study

✍ Scribed by Noriko Usui; Akihiro Takeshita; Chiaki Nakaseko; Nobuaki Dobashi; Hiroyuki Fujita; Hitoshi Kiyoi; Yukio Kobayashi; Toru Sakura; Yuichi Yahagi; Kazuyuki Shigeno; Chikako Ohwada; Yasushi Miyazaki; Shigeki Ohtake; Shuichi Miyawaki; Tomoki Naoe; Kazunori Ohnishi; for the Japan Adult Leukemia Study Group

Book ID: 108587092
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 281 KB
Volume: 102
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2011.01957.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of two schedules of low

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

✍ Sergio Amadori; Stefan Suciu; Dominik Selleslag; Roberto Stasi; Giuliana Alimena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB